Spots Global Cancer Trial Database for pentostatin
Every month we try and update this database with for pentostatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer | NCT00546377 | Leukemia Lymphoma | filgrastim pegfilgrastim rituximab sargramostim cyclophosphamid... mitoxantrone hy... pentostatin fluorescence in... gene rearrangem... polymerase chai... protein express... flow cytometry biopsy | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer | NCT00923845 | Renal Cell Carc... Graft-Versus-Ho... Engraftment Syn... | Pentostatin Sirolimus Cyclophosphamid... Allogeneic Hema... Th2 rapa cells Donor Lymphocyt... Induction Thera... GVHD prophylaxi... Donor Hematopoi... | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Phase II Trial of Pentostatin and Targeted Busulfan | NCT00496340 | Hematologic Mal... | Pentostatin Busulfan Rituximab Allogeneic Hema... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant | NCT00571662 | Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplastic... Multiple Myelom... Non-Hodgkins Ly... Hodgkins Diseas... Peripheral T-ce... | Pentostatin Total-body irra... Cyclosporine A ... Mycophenolate M... G-CSF | 19 Years - 75 Years | University of Nebraska | |
| Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia | NCT01059786 | Hairy Cell Leuk... | Pentostatin Rituximab Bendamustine Acetaminophen Diphenhydramine Epinephrine Antihistamines Corticosteroids Bronchodilators Intravenous (IV... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma | NCT01352312 | Chronic Lymphoc... B-Cell Non-Hodg... | Bendamustine Pentostatin Ofatumumab | 18 Years - | Thomas Jefferson University | |
| SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma | NCT01362790 | Mesothelioma Adenocarcinoma ... Pancreatic Neop... | Pentostatin Cyclophosphamid... SS1(dsFv)PE38 -... SS1(dsFv)PE38 -... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL | NCT00074282 | Leukemia | rituximab cyclophosphamid... pentostatin Alemtuzumab | 18 Years - | Eastern Cooperative Oncology Group | |
| SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma | NCT01362790 | Mesothelioma Adenocarcinoma ... Pancreatic Neop... | Pentostatin Cyclophosphamid... SS1(dsFv)PE38 -... SS1(dsFv)PE38 -... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia | NCT00541034 | Leukemia Lymphoma | rituximab cyclophosphamid... pentostatin | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Alemtuzumab and Pentostatin In T-cell Neoplasms | NCT00453193 | Lymphoma Leukemia | Pentostatin Alemtuzumab | 18 Years - | M.D. Anderson Cancer Center | |
| Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT01024010 | Chronic Lymphoc... Stage 0 Chronic... Stage I Chronic... Stage I Small L... Stage II Chroni... Stage II Small ... Stage III Chron... Stage III Small... Stage IV Chroni... Stage IV Small ... | Cyclophosphamid... Laboratory Biom... Ofatumumab Pentostatin | 18 Years - | Mayo Clinic | |
| Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | NCT00026351 | Leukemia Lymphoma | rituximab pentostatin | 18 Years - | National Cancer Institute (NCI) | |
| Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia | NCT01059786 | Hairy Cell Leuk... | Pentostatin Rituximab Bendamustine Acetaminophen Diphenhydramine Epinephrine Antihistamines Corticosteroids Bronchodilators Intravenous (IV... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase II Trial of Pentostatin and Targeted Busulfan | NCT00496340 | Hematologic Mal... | Pentostatin Busulfan Rituximab Allogeneic Hema... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies | NCT00038025 | Peripheral T-ce... Cutaneous T-cel... Chronic Lymphoc... | Deoxycoformycin... | 16 Years - | M.D. Anderson Cancer Center | |
| Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT | NCT00506922 | Leukemia Lymphoma | Pentostatin Tacrolimus Methotrexate | - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma | NCT00049413 | Leukemia Lymphoma | rituximab cyclophosphamid... pentostatin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation | NCT00698685 | Leukemia Lymphoma Hodgkin's Disea... Hematologic Neo... Multiple Myelom... Carcinoma, Rena... | Pentostatin Alemtuzumab Allogeneic hema... | 18 Years - 75 Years | University of Arizona | |
| Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00602836 | Leukemia Lymphoma | Rituximab Cyclophosphamid... Lenalidomide Pentostatin | 18 Years - 120 Years | Mayo Clinic | |
| Phase II Trial of Pentostatin and Targeted Busulfan | NCT00496340 | Hematologic Mal... | Pentostatin Busulfan Rituximab Allogeneic Hema... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients | NCT00254163 | B-Cell Chronic ... | Fludarabine Cyclophosphamid... Rituximab Pentostatin | 18 Years - | US Oncology Research | |
| Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00602836 | Leukemia Lymphoma | Rituximab Cyclophosphamid... Lenalidomide Pentostatin | 18 Years - 120 Years | Mayo Clinic | |
| Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant | NCT00571662 | Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplastic... Multiple Myelom... Non-Hodgkins Ly... Hodgkins Diseas... Peripheral T-ce... | Pentostatin Total-body irra... Cyclosporine A ... Mycophenolate M... G-CSF | 19 Years - 75 Years | University of Nebraska | |
| Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers | NCT00003658 | Leukemia Lymphoma | filgrastim rituximab cyclophosphamid... pentostatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies | NCT01188798 | Acute Lymphobla... Acute Myelocyti... Chronic Myelocy... Hodgkin's Disea... Myelodysplastic... | Methotrexate Pentostatin | 18 Months - 21 Years | St. Jude Children's Research Hospital | |
| Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers | NCT00003658 | Leukemia Lymphoma | filgrastim rituximab cyclophosphamid... pentostatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer | NCT00816413 | Chronic Myelopr... Leukemia Lymphoma Myelodysplastic... Nonmalignant Ne... | cyclosporine mycophenolate m... pentostatin cytogenetic ana... fluorescence in... protein analysi... flow cytometry immunoenzyme te... laboratory biom... reduced-intensi... nonmyeloablativ... peripheral bloo... total-body irra... | 19 Years - 75 Years | University of Nebraska |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
